Minimal ionizing radiation sensitivity in a large cohort of xeroderma pigmentosum fibroblasts

British Journal of Radiology

Volumn 81, Issue 961, 2008, Pages 51-58

  Arlett, C F ^a   Green, M H L ^b   Rogers, P B ^c,d   Lehmann, A R ^a   Plowman, P N ^c  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b UNIVERSITY OF BRIGHTON   (United Kingdom)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^d ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATAXIA TELANGIECTASIA; CELL CULTURE; COCKAYNE SYNDROME; CONTROLLED STUDY; DATA ANALYSIS; FIBROBLAST; HUMAN; HUMAN CELL; IONIZING RADIATION; PHENOTYPE; RADIOSENSITIVITY; SUN EXPOSURE; XERODERMA PIGMENTOSUM; CELL LINE; CELL SURVIVAL; DOSE RESPONSE; GAMMA RADIATION; PATHOLOGY; RADIATION DOSE; RADIATION EXPOSURE;

ATAXIA TELANGIECTASIA; CELL LINE; CELL SURVIVAL; COCKAYNE SYNDROME; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; GAMMA RAYS; HUMANS; RADIATION TOLERANCE; XERODERMA PIGMENTOSUM;

EID: 38449094426     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/27072321     Document Type: Article

References (50)

1. Arlett CF, Lehmann AR. Xeroderma pigmentosum, cockayne syndrome and trichothiodystrophy: sun sensitivity, DNA repair defects and skin cancer. In Eeles R, Ponder B, Easton DF, Horwich EA, editors. Genetic predisposition to Cancer. London, UK: Arnold; 2004: 214-31.
2. Rogers PB, Plowman PN, Harris SJ, Arlett CF. Four radiation hypersensitivity cases and their implications for clinical radiotherapy. Radiother Oncol 2000;57:143-54.
3. Arlett CF, Plowman PN, Rogers PB, Parris CN, Abbaszadeh F, Green MHL, et al. Clinical and cellular ionizing radiation sensitivity in a patient with xeroderma pigmentosum. Br J Radiol 2006;79:510-7.
4. Mikhelson VM. Defective repair of γ-irradiated DNA in a case of xeroderma pigmentosum. Fort Onkol 1979;4:157-70.
5. Martenstein H, Bobowitcz A. Uber Strahlenempfindlichkeit bei xeroderma pigmentosum (Untersuchungen an einem weiteren fall). Arch Dermatol Syph 1926;150:165-76.
6. Heiner L. Adatok a bor sugarerzekenysegehez xeroderma pigmentosum-nal. Orvosi Hetilap 1925;69:540-2.
7. Ward JF. DNA damage and repair. In Glass WA, Varma MN editors. Physical and Chemical Mechanisms in Molecular Radiation Biology. New York: Plenum Press; 1991: 403-21.
8. Tchou J, Kasai S, Shibutani S, Chung M-H, Laval J, Grollman AP, et al. 8-oxoguanine (8-hydroxyguanine) DNA glycosylase and its substrate specificity. Proc Natl Acad Sci USA 1991;88:4690-4.
9. Wood RD. Nucleotide excision repair in mammalian cells. J Biol Chem 1997;272:23465-8.
10. Masutani C, Kusumoto R, Yamada A, Dohmae N, Yokoi M, Yuasa M, et al. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta. Nature 1999;399:700-4.
11. Lehmann AR. Replication of damaged DNA by translesion synthesis in human cells. FEBS Lett 2005;579:873-6.
12. Arlett CF, Harcourt SA, Lehmann AR, Stevens S, Ferguson-Smith MA, Morley WN. Studies on a new case of xeroderma pigmentosum (XP3BR) from complementation group G with cellular sensitivity to ionizing radiation. Carcinogenesis 1980;1:745-51.
13. Mikhelson VM, Aikazian EV, Center EI, Pleskach NM. Increased sensitivity of human cells to ionizing radiation in one of the forms of the hereditary disease xeroderma pigmentosum (a study of single-stranded DNA breaks and chromosomal aberrations). Tsitologiia 1974;16:203-10.
14. Mikhelson VM, Pleskach NM, Prokofeva VV. Occurrence and elimination of single- and double-strand DNA breaks in the fibroblasts of xeroderma pigmentosum patients exposed to gamma radiation. Tsitologiia 1985;27:592-8.
15. Price FM, Parshad R, Tarone RE, Sanford KK. Radiation-induced chromatid aberrations in Cockayne syndrome and xeroderma pigmentosum group C fibroblasts in relation to cancer predisposition. Cancer Genet Cytogenet 1991;57:1-10.
16. Kim R, Brascho DJ, Lawson AJ. Xeroderma pigmentosum in radiation oncology practice. Int J Radiat Oncol Biol Phys 1982;8:313-4.
17. Sakata K, Aoki Y, Kumakura Y, Karasawa K, Nakagawa K, Muta N, et al. Radiation therapy for patients with xeroderma pigmentosum. Radiat Med 1996;14:87-90.
18. Di Giovanna JJ, Patronas N, Katz D, Abangan D, Kraemer KH. Xeroderma pigmentosum: spinal cord astrocytoma with 9 year survival after radiation and isotretinoin therapy. J Cutan Med Surg 1998;2:153-8.
19. Giglia G, Bouffet E, Jouvet A, Ohgaki H, Kleihues P, Sarasin A. Molecular analysis of glioma and skin-tumour alterations in a xeroderma-pigmentsum child. Int J Cancer 1999;81:345-50.
20. Deschavanne PJ, Chavaudra N, Fertil B, Malaise EP. Abnormal sensitivity of some Cockayne's syndrome cell strains to UV- and gamma-rays. Association with a reduced ability to repair potentially lethal damage. Mutat Res 1984;131:61-70.
21. Lehmann AR. DNA repair-deficient diseases, xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. Biochimie 2003;85:1101-11.
22. Stefanini M, Fawcett H, Botta E, Nardo T, Lehmann AR. Genetic analysis of twenty-two patients with Cockayne syndrome. Hum Genet 1996;97:418-23.
23. Mellon I. Transcription-coupled repair: A complex affair. Mutat Res 2005;577:155-61.
24. de Waard H, de Wit J, Andressoo JO, van Oostrom CT, Riis B, Weimann A, et al. Different effects of CSA and CSB deficiency on sensitivity to oxidative DNA damage. Mol Cell Biol 2004;24:7941-8.
25. Tuo J, Muftuoglu M, Chen C, Jaruga P, Selzer RR, Brosh RM, et al. The Cockayne Syndrome group B gene product is involved in general genome base excision repair of 8-hydroxyguanine in DNA. J Biol Chem 2001;276:45772-9.
26. D'Errico M, Parlanti E, Teson M, Degan P, Lemma T, Calcagnile A, et al. The role of CSA in the response to oxidative DNA damage in human cells. Oncogene 2007;26:4336-43.
27. Green MHL, Arlett CF, Cole J, Harcourt SA, Priestley A, Waugh APW, et al. Comparative human cellular radiosensitivity: III. Gamma-radiation survival of cultured skin fibroblasts and resting T-lymphocytes from the peripheral blood of the same individual. Int J Radiat Biol 1991;59:749-65.
28. Arlett CF, Harcourt SA. Survey of radio -sensitivity in a variety of human cell strains. Cancer Res 1980;40:926-32.
29. Arlett CF, Green MHL, Priestley A, Harcourt SA, Mayne LV. Comparative human cellular radiosensitivity: I. The effect of SV40 immortalisation on the gamma-irradiation survival of skin derived fibroblasts from normal individuals and from ataxia-telangiectasia patients and heterozygotes. Int J Radiat Biol 1988;54:911-28.
30. Stankovic T, Kidd AMJ, Sutcliffe A, McGuire GM, Robinson P, Weber P, et al. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am J Hum Genet 1998;62:334-45.
31. McConville CM, Stankovic T, Byrd PJ, McGuire G, Yao Q-Y, Lennox GG, et al. Mutations associated with variant phenotypes in ataxia telangeictasia. Am J Hum Genet 1996;59:320-30.
32. Barenfeld LS, Pleskach NM, Bildin VN, Prokofjeva VV, Mikhelson VM. Radioresistant DNA synthesis in cells of patients showing increased chromosomal sensitivity to ionizing radiation. Mutat Res 1986;165:159-64.
33. Arlett CF. Human cellular radiosensitivity - the search for the holy grail or a poisoned chalice. Adv Radiat Biol 1992;16:273-92.
34. Jaeken J, Klocker H, Schwaiger H, Bellmann R, Hirschkauffmann M, Schweiger M. Clinical and biochemical-studies in three patients with severe early infantile Cockayne syndrome. Hum Genet 1989;83:339-46.
35. Vermeulen W, Scott RJ, Rodgers S, Muller HJ, Cole J, Arlett CF, et al. Clinical heterogeneity within xeroderma pigmentosum associated with mutations in the DNA repair and transcription gene ERCC3. Am J Hum Genet 1994;54:191-200.
36. Lalle P, Nouspikel T, Constantinou A, Thorel F, Clarkson SG. The founding members of xeroderma pigmentosum group G produce XPG protein with severely impaired endonuclease activity. J Invest Dermatol 2002;118:344-51.
37. Taylor EM, Broughton BC, Botta E, Stefanini M, Sarasin A, Jaspers NGJ, et al. Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene. Proc Natl Acad Sci USA 1997;94:8658-63.
38. Chavanne F, Broughton BC, Pietra D, Nardo T, Browitt A, Lehmann AR, et al. Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels. Cancer Res 2000;60:1974-82.
39. Broughton BC, Thompson AF, Harcourt SA, Vermeulen W, Hoeijmakers JHJ, Botta E, et al. Molecular and cellular analysis of the DNA-repair defect in a patient in Xeroderma-pigmentosum complementation Group-D who has the clinical-features of Xeroderma-pigmentosum and Cockayne-syndrome. Am J Hum Genet 1995;56:167-74.
40. Broughton BC, Cordonnier A, Kleijer WJ, Jaspers NGJ, Fawcett H, Raams A, et al. Molecular analysis of mutations in DNA polymerase eta in xeroderma pigmentosum-variant patients. Proc Natl Acad Sci USA 2002;99:815-20.
41. States JC, McDuffie ER, Myrand SP, McDowell M, Cleaver JE. Distribution of mutations in the human xeroderma pigmentosum group A gene and their relationships to the functional regions of the DNA damage recognition protein. Hum Mutat 1998;12:103-13.
42. Pawsey SA, Magnus IA, Ramsay CA, Benson PF, Giannelli F. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum. Quart J Medicine 1979;190:179-210.
43. Nouspikel T, Clarkson SG. Mutations that disable the DNA-repair gene XPG in a Xeroderma-pigmentosum group-G patient. Hum Mol Genet 1994;3:963-7.
44. Petit-Frère C, Capulas E, Lowe JE, Koulu L, Marttila RJ, Jaspers NGJ, et al. Ultraviolet-B-induced apoptosis and cytokine release in xeroderma pigmentosum keratinocytes. J Invest Dermatol 2000;115:687-93.
45. Nouspikel T, Lalle P, Leadon SA, Cooper PK, Clarkson SG. A common mutational pattern in Cockayne syndrome patients from xeroderma pigmentosum group G: implications for a second XPG function. Proc Natl Acad Sci USA 1997;94:3116-21.
46. Troelstra C, van Gool A, de Wit J, Vermeulen W, Bootsma D, Hoeijmakers JHJ. ERCC6, a member of a subfamily of putative helicases, is involved in Cockayne's syndrome and preferential repair of active genes. Cell 1992;71:939-53.
47. Lehmann AR. Three complementation groups in Cockayne syndrome. Mutat Res 1982;106:347-56.
48. Mallery DL, Tanganelli B, Colella S, Steingrimsdottir H, Van Gool AJ, Troelstra C, et al. Molecular analysis of mutations in the CSB(ERCC6) gene in patients with Cockayne syndrome. Am J Hum Genet 1998;62:77-85.
49. Huschtscha LI, Holliday R. Limited and unlimited growth of SV40-transformed cells from human diploid MRC-5 fibroblasts. J Cell Sci 1983;63:77-99.
50. Jacobs JP, Jones CM, Baillie JP. Characteristics of a human diploid cell designated MRC-5. Nature 1970;227:168-70.